PALB2, partner and localizer of BRCA2, 79728
N. diseases: 260; N. variants: 410
Source: ALL
Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.716 | 0.520 | 16 | 23607891 | frameshift variant | T/- | del | 2.1E-05 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 3 | 2009 | 2014 | |||||||
|
1.000 | 0.080 | 16 | 23608013 | splice acceptor variant | C/G;T | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 3 | 2007 | 2014 | ||||||||
|
1.000 | 0.080 | 16 | 23641109 | splice donor variant | C/G;T | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 3 | 2007 | 2014 | ||||||||
|
0.882 | 0.240 | 16 | 23629986 | frameshift variant | AT/- | del | 6.4E-05 | 2.1E-05 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 3 | 2014 | 2014 | ||||||
|
0.925 | 0.080 | 16 | 23629276 | splice acceptor variant | C/A;G;T | snv | 4.0E-06 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 3 | 2007 | 2014 | |||||||
|
1.000 | 0.080 | 16 | 23630034 | frameshift variant | G/- | delins | 8.0E-06 | 2.1E-05 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 3 | 2015 | 2016 | ||||||
|
1.000 | 0.080 | 16 | 23630230 | frameshift variant | T/- | delins |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 3 | 2013 | 2016 | ||||||||
|
1.000 | 0.080 | 16 | 23629742 | frameshift variant | AG/- | delins | 2.1E-05 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 3 | 2014 | 2016 | |||||||
|
1.000 | 0.080 | 16 | 23630170 | stop gained | T/A | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 2 | 2015 | 2017 | ||||||||
|
1.000 | 0.080 | 16 | 23635121 | frameshift variant | -/G | delins |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 2 | 2015 | 2018 | ||||||||
|
1.000 | 0.080 | 16 | 23635795 | stop gained | G/A | snv | 7.0E-06 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 2 | 2009 | 2015 | |||||||
|
1.000 | 0.080 | 16 | 23635489 | frameshift variant | CT/- | delins | 4.0E-06 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 2 | 2009 | 2017 | |||||||
|
0.827 | 0.400 | 16 | 23635306 | stop gained | G/A | snv | 8.0E-06 | 1.4E-05 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 2 | 2010 | 2011 | ||||||
|
1.000 | 0.080 | 16 | 23634954 | frameshift variant | AA/-;A | delins | 1.8E-04 | 1.3E-04 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 2 | 2007 | 2008 | ||||||
|
1.000 | 0.080 | 16 | 23634913 | stop gained | C/A;T | snv | 4.0E-06 | 7.0E-06 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 2 | 2011 | 2014 | ||||||
|
0.925 | 0.200 | 16 | 23623044 | frameshift variant | TT/- | delins |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 2 | 2011 | 2016 | ||||||||
|
0.807 | 0.240 | 16 | 23614089 | frameshift variant | T/- | delins | 1.2E-05 | 1.4E-05 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 2 | 2007 | 2015 | ||||||
|
0.925 | 0.080 | 16 | 23638106 | frameshift variant | C/- | del |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 2 | 2011 | 2014 | ||||||||
|
0.925 | 0.160 | 16 | 23635493 | frameshift variant | TTTG/- | delins | 7.0E-06 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 2 | 2013 | 2016 | |||||||
|
1.000 | 0.080 | 16 | 23635067 | frameshift variant | G/- | delins | 1.2E-05 | 2.1E-05 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 2 | 2012 | 2014 | ||||||
|
1.000 | 0.080 | 16 | 23637905 | frameshift variant | T/- | del | 7.0E-06 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 2 | 2014 | 2015 | |||||||
|
1.000 | 0.080 | 16 | 23636095 | stop gained | G/A;T | snv | 4.0E-06 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 2 | 2014 | 2017 | |||||||
|
1.000 | 0.080 | 16 | 23629645 | stop gained | C/A;G;T | snv | 1.0E-04 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 2 | 2015 | 2015 | |||||||
|
1.000 | 0.080 | 16 | 23636122 | stop gained | T/A | snv | 8.0E-06 | 1.4E-05 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 2 | 2015 | 2017 | ||||||
|
1.000 | 0.080 | 16 | 23635947 | frameshift variant | A/- | delins | 4.0E-06 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 2 | 2016 | 2017 |